These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 29979531)

  • 1. [Development of Recombinant Human Monoclonal Antibody Cocktail for Post-exposure Rabies Prophylaxis].
    Sun L; Liu Y; Li C; Li D; Liang M
    Bing Du Xue Bao; 2016 Jul; 32(4):399-403. PubMed ID: 29979531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of broad-spectrum human monoclonal antibodies for rabies post-exposure prophylaxis.
    De Benedictis P; Minola A; Rota Nodari E; Aiello R; Zecchin B; Salomoni A; Foglierini M; Agatic G; Vanzetta F; Lavenir R; Lepelletier A; Bentley E; Weiss R; Cattoli G; Capua I; Sallusto F; Wright E; Lanzavecchia A; Bourhy H; Corti D
    EMBO Mol Med; 2016 Apr; 8(4):407-21. PubMed ID: 26992832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SYN023, a novel humanized monoclonal antibody cocktail, for post-exposure prophylaxis of rabies.
    Chao TY; Ren S; Shen E; Moore S; Zhang SF; Chen L; Rupprecht CE; Tsao E
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006133. PubMed ID: 29261658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient In Vitro and In Vivo Activity of Glyco-Engineered Plant-Produced Rabies Monoclonal Antibodies E559 and 62-71-3.
    Tsekoa TL; Lotter-Stark T; Buthelezi S; Chakauya E; Stoychev SH; Sabeta C; Shumba W; Phahladira B; Hume S; Morton J; Rupprecht CE; Steinkellner H; Pauly M; Zeitlin L; Whaley K; Chikwamba R
    PLoS One; 2016; 11(7):e0159313. PubMed ID: 27427976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering, expression in transgenic plants and characterisation of E559, a rabies virus-neutralising monoclonal antibody.
    van Dolleweerd CJ; Teh AY; Banyard AC; Both L; Lotter-Stark HC; Tsekoa T; Phahladira B; Shumba W; Chakauya E; Sabeta CT; Gruber C; Fooks AR; Chikwamba RK; Ma JK
    J Infect Dis; 2014 Jul; 210(2):200-8. PubMed ID: 24511101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A recombinant rabies virus encoding two copies of the glycoprotein gene confers protection in dogs against a virulent challenge.
    Liu X; Yang Y; Sun Z; Chen J; Ai J; Dun C; Fu ZF; Niu X; Guo X
    PLoS One; 2014; 9(2):e87105. PubMed ID: 24498294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and evaluation of an anti-rabies virus phosphoprotein-specific monoclonal antibody for detection of rabies neutralizing antibodies using RFFIT.
    Um J; Chun BC; Lee YS; Hwang KJ; Yang DK; Park JS; Kim SY
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006084. PubMed ID: 29267277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of reducing rabies immunoglobulin dosage for passive immunization against rabies: results of In vitro and In vivo studies.
    Madhusudana SN; Ashwin BY; Sudarshan S
    Hum Vaccin Immunother; 2013 Sep; 9(9):1914-7. PubMed ID: 23792347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a human antibody fragment Fab and its calcium phosphate nanoparticles that inhibit rabies virus infection with vaccine.
    Liu X; Lin H; Tang Q; Li C; Yang S; Wang Z; Wang C; He Q; Cao B; Feng Z; Guan X; Zhu J
    PLoS One; 2011 May; 6(5):e19848. PubMed ID: 21573024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating antibody neutralization of lyssaviruses using lentiviral pseudotypes: a cross-species comparison.
    Wright E; Temperton NJ; Marston DA; McElhinney LM; Fooks AR; Weiss RA
    J Gen Virol; 2008 Sep; 89(Pt 9):2204-2213. PubMed ID: 18753230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cross-reactive mouse monoclonal antibody against rhinovirus mediates phagocytosis in vitro.
    Behzadi MA; Choi A; Duehr J; Feyznezhad R; Upadhyay C; Schotsaert M; Palese P; Nachbagauer R
    Sci Rep; 2020 Jun; 10(1):9750. PubMed ID: 32546721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of trimeric pre-fusion rabies virus glycoprotein in complex with two protective antibodies.
    Ng WM; Fedosyuk S; English S; Augusto G; Berg A; Thorley L; Haselon AS; Segireddy RR; Bowden TA; Douglas AD
    Cell Host Microbe; 2022 Sep; 30(9):1219-1230.e7. PubMed ID: 35985336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo evaluation of a single chain antibody fragment generated in planta with potent rabies neutralisation activity.
    Phoolcharoen W; Banyard AC; Prehaud C; Selden D; Wu G; Birch CPD; Szeto TH; Lafon M; Fooks AR; Ma JK
    Vaccine; 2019 Aug; 37(33):4673-4680. PubMed ID: 29523449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of the prefusion-locking broadly neutralizing antibody RVC20 bound to the rabies virus glycoprotein.
    Hellert J; Buchrieser J; Larrous F; Minola A; de Melo GD; Soriaga L; England P; Haouz A; Telenti A; Schwartz O; Corti D; Bourhy H; Rey FA
    Nat Commun; 2020 Jan; 11(1):596. PubMed ID: 32001700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and identification of anti-rabies virus monoclonal antibodies.
    Wang WJ; Li X; Wang LH; Shan H; Cao L; Yu PC; Tang Q; Liang GD
    Virol Sin; 2012 Jun; 27(3):172-8. PubMed ID: 22684471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel ELISA for quantification of glycoprotein in human rabies vaccines using a clinically proven virus neutralizing human monoclonal antibody.
    Gairola S; Gautam M; Waghmare S
    Hum Vaccin Immunother; 2020 Aug; 16(8):1857-1865. PubMed ID: 31971485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal Antibody Cocktail Protects Hamsters From Lethal Marburg Virus Infection.
    Marzi A; Haddock E; Kajihara M; Feldmann H; Takada A
    J Infect Dis; 2018 Nov; 218(suppl_5):S662-S665. PubMed ID: 29889266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic study and preliminary evaluation of safety and efficacy of the recombinant human monoclonal antibodies against rabies virus (rhRIG) in Chinese healthy population: A randomized, single-blinded, placebo-controlled phase Ia clinical trial.
    Chen X; Duan J; Li Y; Zhao Q; Zhao Y; Yu L; Li X; Wang H
    Travel Med Infect Dis; 2023; 55():102645. PubMed ID: 37778451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Function and glycosylation of plant-derived antiviral monoclonal antibody.
    Ko K; Tekoah Y; Rudd PM; Harvey DJ; Dwek RA; Spitsin S; Hanlon CA; Rupprecht C; Dietzschold B; Golovkin M; Koprowski H
    Proc Natl Acad Sci U S A; 2003 Jun; 100(13):8013-8. PubMed ID: 12799460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two recombinant human monoclonal antibodies that protect against lethal Andes hantavirus infection in vivo.
    Garrido JL; Prescott J; Calvo M; Bravo F; Alvarez R; Salas A; Riquelme R; Rioseco ML; Williamson BN; Haddock E; Feldmann H; Barria MI
    Sci Transl Med; 2018 Nov; 10(468):. PubMed ID: 30463919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.